VC firms take osteoporosis drugmaker Radius Health private for almost $900M

VC firms take osteoporosis drugmaker Radius Health private for almost $900M

Source: 
Endpoints
snippet: 

Radius Health, a biotech out of Massachusetts with one approved product in its arsenal, announced Thursday morning that it agreed to be acquired by two VC firms: Gurnet Point Capital and Patient Square Capital. The deal, worth around $890 million, will include debt assumption and the payout of $1 CVR per share for investors. And on top of that, OrbiMed is providing debt financing.